NO20023951L - Arylpiperaziner og arylpiperidiner og deres anvendelse som metalloproteinaseinhiberende midler - Google Patents

Arylpiperaziner og arylpiperidiner og deres anvendelse som metalloproteinaseinhiberende midler

Info

Publication number
NO20023951L
NO20023951L NO20023951A NO20023951A NO20023951L NO 20023951 L NO20023951 L NO 20023951L NO 20023951 A NO20023951 A NO 20023951A NO 20023951 A NO20023951 A NO 20023951A NO 20023951 L NO20023951 L NO 20023951L
Authority
NO
Norway
Prior art keywords
arylpiperidines
arylpiperazines
metalloproteinase inhibitors
inhibitors
metalloproteinase
Prior art date
Application number
NO20023951A
Other languages
English (en)
Other versions
NO20023951D0 (no
Inventor
Bernard Christophe Barlaam
Robert Ian Dowell
Nicholas John Newcombe
Howard Tucker
David Waterson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20023951L publication Critical patent/NO20023951L/no
Publication of NO20023951D0 publication Critical patent/NO20023951D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Forbindelser av formel (I). som er nyttige som metalloproteinaseinhibitorer, spesielt som inhibitorer av MMP 13.
NO20023951A 2000-02-21 2002-08-20 Arylpiperaziner og arylpiperidiner og deres anvendelse som metalloproteinaseinhiberende midler NO20023951D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00400469 2000-02-21
PCT/GB2001/000616 WO2001062751A1 (en) 2000-02-21 2001-02-15 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents

Publications (2)

Publication Number Publication Date
NO20023951L true NO20023951L (no) 2002-08-20
NO20023951D0 NO20023951D0 (no) 2002-08-20

Family

ID=8173566

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023951A NO20023951D0 (no) 2000-02-21 2002-08-20 Arylpiperaziner og arylpiperidiner og deres anvendelse som metalloproteinaseinhiberende midler

Country Status (13)

Country Link
US (1) US20030139419A1 (no)
EP (1) EP1261595A1 (no)
JP (1) JP2003524008A (no)
KR (1) KR20020079882A (no)
CN (1) CN1404474A (no)
AU (1) AU3385401A (no)
BR (1) BR0108500A (no)
CA (1) CA2396971A1 (no)
IL (1) IL150882A0 (no)
MX (1) MXPA02008112A (no)
NO (1) NO20023951D0 (no)
WO (1) WO2001062751A1 (no)
ZA (1) ZA200205845B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0119473D0 (en) * 2001-08-09 2001-10-03 Astrazeneca Compounds
GB0119472D0 (en) * 2001-08-09 2001-10-03 Astrazeneca Ab Compounds
GB0119474D0 (en) 2001-08-09 2001-10-03 Astrazeneca Ab Compounds
JP4606027B2 (ja) 2002-04-03 2011-01-05 トポターゲット ユーケー リミテッド Ｈｄａｃ阻害剤としてのピペラジン結合を有するカルバミン酸化合物
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
US7465719B2 (en) 2003-01-17 2008-12-16 Topotarget Uk Limited Carbamic acid compounds comprising an ester or ketone linkage as HDAC inhibitors
WO2004078751A1 (ja) 2003-03-07 2004-09-16 Kowa Co., Ltd. ベンゾフラン誘導体
CA2528317A1 (en) * 2003-06-19 2004-12-29 Celltech R & D Limited Hydroxamate sulfonamides as cd23 shedding inhibitors
US20060241118A1 (en) * 2004-06-18 2006-10-26 Celltech R&D Limited Hydroxamate sulfonamides as cd23 shedding inhibitors
KR100838645B1 (ko) * 2006-09-28 2008-06-16 한국화학연구원 베타-세크리테아제 활성을 억제하는 피페리딘 화합물
BR112021006407A8 (pt) 2018-10-04 2022-12-06 Inst Nat Sante Rech Med uso de inibidores do egfr para ceratodermas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69729007T2 (de) * 1996-08-07 2005-04-07 Darwin Discovery Ltd., Slough Hydroxamsäure- und carbonsäure-derivate mit mmp und tnf hemmender wirkung
AU743901B2 (en) * 1996-10-16 2002-02-07 Wyeth Holdings Corporation Ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloprote inase and tace inhibitors
GB9725782D0 (en) * 1997-12-05 1998-02-04 Pfizer Ltd Therapeutic agents
EP1107953A1 (en) * 1998-08-29 2001-06-20 British Biotech Pharmaceuticals Limited Hydroxamic acid derivatives as proteinase inhibitors
GB9919776D0 (en) * 1998-08-31 1999-10-27 Zeneca Ltd Compoujnds

Also Published As

Publication number Publication date
US20030139419A1 (en) 2003-07-24
MXPA02008112A (es) 2002-11-29
CN1404474A (zh) 2003-03-19
BR0108500A (pt) 2003-04-29
NO20023951D0 (no) 2002-08-20
WO2001062751A1 (en) 2001-08-30
AU3385401A (en) 2001-09-03
JP2003524008A (ja) 2003-08-12
EP1261595A1 (en) 2002-12-04
CA2396971A1 (en) 2001-08-30
ZA200205845B (en) 2003-10-22
KR20020079882A (ko) 2002-10-19
IL150882A0 (en) 2003-02-12

Similar Documents

Publication Publication Date Title
TR200100605T2 (tr) Arilpiperazinler ve bunların metaloproteinaz inhibe edici maddeler (MMP) olarak kullanımı
ATE227264T1 (de) Metalloproteinase-inhibitoren
MY136789A (en) Metalloproteinase inhibitors
NO20031001L (no) Polyarylkarboksamider nyttige som lipidsenkende midler
DK1542977T3 (da) 2,5-dioxoimidazolidin-4-ylacetamider og analoger som inhibitorer af metalloproteinase MMP12
IS7721A (is) Píperidín-pýrídasón og þalasón sem PDE4 hemlar
NO20025811L (no) Forbindelser som er effektive som beta-2-adrenoreseptor- agonister så vel som PDE4-inhibitorer
NO20023951L (no) Arylpiperaziner og arylpiperidiner og deres anvendelse som metalloproteinaseinhiberende midler
ATE411287T1 (de) Neue metallproteinaseinhibitoren
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
NO20015892L (no) Inhibitorer av metallproteinaser
BG107003A (en) Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
ATE288922T1 (de) Bestimmte heteroaryl substituierte thiol inhibitoren von endothelin wechselnden enzymen
ATE287403T1 (de) 6-phenylbenzonaphthyidine
EA200301101A1 (ru) Производные пиперазина и их применение в качестве ингибиторов pde4
NO20030675L (no) Nye amidinoderivater og deres anvendelse som trombininhibitorer
EA200600608A1 (ru) Производные имидазопиридина как ингибиторы индуцируемой no-синтазы
HRP20030653B1 (en) Novel benzoylguanidine salt
DK1358182T3 (da) Diazocin-derivater og anvendelsen deraf som tryptase-inhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application